The beneficial effects of short-chain fatty acids include the anti-inflammatory action due to strengthened intestinal tract barrier function and anti-obesity effect due to increased energy consumption through GPR41 and GPR43 in the liver [36,37,38]. The gene discussed is FFAR2; the disease is obesity disorder.